计算机辅助药物分子设计在抗糖尿病PPARs调节剂方面的应用及研究进展 |
| |
引用本文: | 李雅潇,雷鹏森[综述],李爱秀[审校]. 计算机辅助药物分子设计在抗糖尿病PPARs调节剂方面的应用及研究进展[J]. 武警医学院学报, 2014, 0(1): 73-79 |
| |
作者姓名: | 李雅潇 雷鹏森[综述] 李爱秀[审校] |
| |
作者单位: | [1]武警后勤学院部队卫生学教研室,天津300309 [2]武警后勤学院基础部化学教研室,天津300309 [3]武警后勤学院天津市职业与环境危害生物标志物重点实验室,天津300309 |
| |
摘 要: | 过氧化物酶体增殖激活受体是一类与调节体内糖脂代谢,改善胰岛素抵抗密切相关的受体。而计算机辅助药物分子设计越来越成为新药开发领域重要的研究热点,它的发展和应用,大大提高了药物设计和新药开发的效率。本文将对计算机辅助药物分子设计在抗糖尿病PPARs调节剂方面的应用及研究进展加以综述。
|
关 键 词: | PPARs调节剂 计算机辅助药物分子设计 糖尿病 |
Application and progress in computer-aid drug design on ppars regulator |
| |
Affiliation: | LI Ya-xiao, LEI Peng-sen, LI Ai-xiu (Department of Military Hygiene, Logistic University of PAPF, Tianjin 300309, China) |
| |
Abstract: | Peroxisome proliferator-activated receptors are a series of receptors related to metabolism of sugar and lipid and amelioration of insulin resistance. On the other hand, Computer-aid drug design has become the hot spot in the research of new drug design. Its appearance and development has greatly improvd the efficiency of development of new drug. Application and progress in Computer-aid Drug Design on PPARs regulators are summarized in this article. |
| |
Keywords: | PPARs regulator Computer-aid drug design Diabetes |
本文献已被 维普 等数据库收录! |
|